New Chicco Bottles Study

NCT ID: NCT03311282

Last Updated: 2017-10-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

61 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-06-12

Study Completion Date

2015-01-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Breastfeeding is recommended as the ideal form of nutrition for newborns and infants at least for the first 6 months of life by several Institutions such as the American Academy of Pediatrics (AAP) and the World Health Organization (WHO).

When breastfeeding is not possible or not desirable, bottle-feeding, in most cases using a proper infant formula, is the right alternative.

Both facial and cranial growth and development rely on genetic and external stimuli; the latter are provided also by activities of sucking, swallowing and chewing. Considering this, it is important to show the differences between the activities of the muscles (masseter, temporalis and buccinator) in charge of sucking during breastfeeding or bottle-feeding.

The activities of the muscles were evaluated through SLI, which consists of the assessment of muscle functioning by analyzing the displacement of a defined point on a given muscle. This displacement is tracked over time with respect to a fixed frame of reference, thus providing velocity data (i.e. speed) for a certain point on the muscle during muscle contraction. The use of SLI allowed us to determine the activity of oral muscles on the different types of feeding and to compare their strength and activity.

Principal aims of the present study was to assess the activity of the orbicularis oris muscle (OM) and of the masseter, temporalis and buccinator muscles (MM, TM and BM) (i.e. the muscles in charge of sucking during breastfeeding) during breastfeeding and bottle-feeding by means of SLI. The new Chicco feeding bottles Natural Feeling (Natural Fit) 0m+, 4m+ and 6m+ were used according to the age of the infants.

Moreover, the following parameters were evaluated comparing breastfeeding and bottle-feeding: feeding efficiency (measured as ml/minute milk intake considering an interval of 15 minutes) and oxygen saturation during feeding (assessed by pulse oximetry). Moreover colic-like symptoms over 9 weeks (0 to 4 weeks infant only) were evaluated through the Infant Colic Scale.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

By means of SLI technique positive preliminary results as regards comparison between bottle feeding with the New Chicco Bottles and breastfeeding were reached; these results allow to conclude that, considering feeding features related to growth and development, bottle-feeding with the new Chicco bottles can biomimic the suction muscular dynamics of breastfeeding.

A proper growth is confirmed in bottle-feeding groups also by means of evaluations of growth parameters, and it is guaranteed by the evaluation of the oxygen saturation during feeding, that is similar among groups.

As regards evaluation of colic underlying causes in infants ages 0-4 weeks it is possible to state that no differences were found in bottle-fed and breastfed infants: given the lack of differences between the groups, whichever the underlying reason for colic symptomatology could exist, it is possible to infer that using one or the other kind of feeding does not have an impact on symptoms, or had a minor one.

As regards the product satisfaction evaluated comparing the bottle-fed groups positive results were reached in all the evaluation, at V2, Week 5 and Week 9, reaching always a mean score \> 8.

Notwithstanding the positive results above outlined a confirmatory study, envisaging a bigger sample size, it is advisable, to confirm and emphasize the results already achieved.

For each trial participant the adverse events/serious adverse events occurrences and a brief clinical examination were assessed during Visits. No special or unusual features of the safety evaluations were found.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Feeding Behavior

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

breastfeeding infants squeezing breathing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Treatment groups: bottle-fed infants

* Group 1: 10 infants aged 0-4 weeks (+/- 7 days): 0-4 m bottle
* Group 2: 10 infants aged 4 months (+/- 10 days): 4-6 m bottle
* Group 3: 10 infants aged 6-10 months (+/- 10 days): 6m+ bottle Control groups: exclusively or prevalently breast-fed infants
* Group 4: 10 infants aged 0-4 weeks (+/- 7 days)
* Group 5: 10 infants aged 4 months (+/- 10 days)
* Group 6: 10 infants aged 6-10 months (+/- 10 days) (at least 2 breastfeeding sessions per day)

Number of subjects enrolled and allocated: 61 healthy infants, both male and female as follows:

Treatment groups: bottle-fed infants

* Group 1: 11 infants aged 0-4 weeks (+/- 7 days): 0-4 m bottle
* Group 2: 10 infants aged 4 months (+/- 10 days): 4-6 m bottle
* Group 3: 10 infants aged 6-10 months (+/- 10 days): 6m+ bottle Control groups: exclusively or prevalently breast-fed infants
* Group 4: 10 infants aged 0-4 weeks (+/- 7 days)
* Group 5: 10 infants aged 4 months (+/- 10 days)
Primary Study Purpose

OTHER

Blinding Strategy

NONE

This was a prospective, open-label, monocentric, interventional clinical study.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Feeding Bottle 0m+

10 infants aged 0-4 weeks (+/- 7 days): 0-4 m bottle. 0-4 months, 250 ml, 2 angled teats: newborn (also referred to as low flow) and infant (also referred to as medium flow), for infants aged 0-4 weeks (+/- 7 days) / over 9 weeks of participation.

Group Type EXPERIMENTAL

infants bottles

Intervention Type DEVICE

* angled/inclined teat that remains full of milk throughout the feeding to prevent the risk of air ingestion, gassy colic, hiccups and regurgitation and to keep the infant's neck in the right position;
* extra-large, soft and rounded base to ensure maximum simulation of the maternal breast and a wide latch on for a correct suckling motion
* flexors at the base to enhance elasticity and flexibility of the teat

Feeding Bottle 4m+

10 infants aged 4 months (+/- 10 days): 4-6 m bottle. 4-6 months, 250 ml, non-angled teat), for infants aged 4 months (+/- 10 days) / over 9 weeks of participation.

Group Type EXPERIMENTAL

Infants Bottles

Intervention Type DEVICE

* large, rounded and soft teat to ensure maximum simulation of the maternal breast and a wide latch on for a correct suckling motion
* non-inclined shape of the teat ideal from 4 months onwards, when the colic episodes have subsided and infant has more control of the neck.
* flexors at the base to enhance elasticity and flexibility of the teat

Feeding Bottle 6m+

10 infants aged 6-10 months (+/- 10 days): 6m+ bottle. 6 months and over, 250 ml, longer teat) for infants aged form 6 to 10 months (+/- 10 days) / over 9 weeks of participation.

Group Type EXPERIMENTAL

Infants Bottles

Intervention Type DEVICE

* teat with less rounded base to guarantee tighter lip support, which helps the "sucking" motion.
* flexors at the base to enhance elasticity and flexibility of the teat

exclusively or prevalently breast-fed infants 0m+

10 infants aged 0-4 weeks (+/- 7 days)

Group Type NO_INTERVENTION

No interventions assigned to this group

exclusively or prevalently breast-fed infants 4m+

10 infants aged 4 months (+/- 10 days)

Group Type NO_INTERVENTION

No interventions assigned to this group

exclusively or prevalently breast-fed infants 6m+

10 infants aged 6-10 months (+/- 10 days) (at least 2 breastfeeding sessions per day)

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

infants bottles

* angled/inclined teat that remains full of milk throughout the feeding to prevent the risk of air ingestion, gassy colic, hiccups and regurgitation and to keep the infant's neck in the right position;
* extra-large, soft and rounded base to ensure maximum simulation of the maternal breast and a wide latch on for a correct suckling motion
* flexors at the base to enhance elasticity and flexibility of the teat

Intervention Type DEVICE

Infants Bottles

* large, rounded and soft teat to ensure maximum simulation of the maternal breast and a wide latch on for a correct suckling motion
* non-inclined shape of the teat ideal from 4 months onwards, when the colic episodes have subsided and infant has more control of the neck.
* flexors at the base to enhance elasticity and flexibility of the teat

Intervention Type DEVICE

Infants Bottles

* teat with less rounded base to guarantee tighter lip support, which helps the "sucking" motion.
* flexors at the base to enhance elasticity and flexibility of the teat

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Natural Feeling/Natural Fit 0-4m: Natural Feeling/Natural Fit 4-6m: Natural Feeling/Natural Fit 6m+:

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female infants aged 0 to 10 months according to the following:

Group 1: age 0-4 weeks (+/- 7 days) Group 2: age 4 months (+/- 10 days) Group 3: age 6-10 months (+/- 10 days) Group 4: age 0-4 weeks (+/- 7 days) Group 5: age 4 months (+/- 10 days) Group 6: age 6-10 months (+/- 10 days)

* Infants exclusively or prevalently breast- or bottle-fed
* Full-term infants (≥ 37 weeks of gestation) with APGAR at birth (5 min) ≥ 8 by parent report
* Birth weight ≥ 2.5 kg by parent report
* Capability of the parents / legal guardians, according to Investigator's opinion, to fully comprehend the nature of the study
* Parents / legal guardians' written consent to the study and willingness to comply with study procedures

Exclusion Criteria

* Birth defect, injury or health condition that interferes with sucking, feeding or breathing
* Any medical condition or disease that may affect subject safety or confound study results, including cardiac or neurological defects
* Infants born from twin or multiple pregnancy
* Any other condition that, in the Investigator's opinion, may preclude the subject's ability to safely complete the trial
* Parents / legal guardians uncooperative and/or non-compliant according to Investigator's opinion
Minimum Eligible Age

1 Day

Maximum Eligible Age

10 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Artsana S.p.a.

INDUSTRY

Sponsor Role collaborator

Sprim Advanced Life Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Art001

Identifier Type: -

Identifier Source: org_study_id